화학공학소재연구정보센터
검색결과 : 7건
No. Article
1 The human rhabdomyosarcoma cell line TE671-Towards an innovative production platform for glycosylated biopharmaceuticals
Rosenlocher J, Weilandt C, Sandig G, Reinke SO, Blanchard V, Hinderlich S
Protein Expression and Purification, 115, 83, 2015
2 No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation
Salama I, Hinderlich S, Shlomai Z, Eisenberg I, Krause S, Yarema K, Argov Z, Lochmuller H, Reutter W, Dabby R, Sadeh M, Ben-Bassat H, Mitrani-Rosenbaum S
Biochemical and Biophysical Research Communications, 328(1), 221, 2005
3 UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, functionally expressed in and purified from Escherichia coli, yeast, and insect cells
Blume A, Ghaderi D, Liebich V, Hinderlich S, Donner P, Reutter W, Lucka L
Protein Expression and Purification, 35(2), 387, 2004
4 Epigenetically mediated loss of UDP-GlcNAc 2-epimerase/ManNAc kinase expression in hyposialylated cell lines
Oetke C, Hinderlich S, Reutter W, Pawlita M
Biochemical and Biophysical Research Communications, 308(4), 892, 2003
5 Sialic acid biosynthesis: Stereochemistry and mechanism of the reaction catalyzed by the mammalian UDP-N-acetylglucosamine 2-epimerase
Chou WK, Hinderlich S, Reutter W, Tanner ME
Journal of the American Chemical Society, 125(9), 2455, 2003
6 Identification of human L-fucose kinase amino acid sequence
Hinderlich S, Berger M, Blume A, Chen H, Ghaderi D, Bauer C
Biochemical and Biophysical Research Communications, 294(3), 650, 2002
7 UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation
Keppler OT, Hinderlich S, Langner J, Schwartz-Albiez R, Reutter W, Pawlita M
Science, 284(5418), 1372, 1999